Stocktoria
Airsculpt Technologies, Inc. AIRS
Nasdaq · XNAS · stock · Services-Offices & Clinics of Doctors of Medicine · website · IPO 2021-10-29
Airsculpt Technologies, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -7.6% | -0.9% | 5.0% | -2.7% | 11.8% |
| Net margin | -7.7% | -4.4% | -2.2% | -8.7% | 7.9% |
| FCF margin | 0.5% | -1.5% | 7.2% | 6.8% | 14.6% |
| Return on assets | -6.2% | -3.8% | -2.1% | -7.3% | 5.3% |
| Return on equity | -13.3% | -10.3% | -5.1% | -20.7% | 12.6% |
| Debt / equity | 0.64× | 0.89× | 0.87× | 1.18× | 0.99× |
| Current ratio | 0.55 | 0.59 | 0.79 | 0.75 | 1.79 |
| Revenue growth | -15.8% | -7.9% | 16.1% | 26.6% | 112.4% |
Source: SEC EDGAR filings · CIK 0001870940 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.